NXPH2 抗体 (AA 23-264)
Quick Overview for NXPH2 抗体 (AA 23-264) (ABIN7161230)
抗原
See all NXPH2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 23-264
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Neurexophilin-2 protein (23-264AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: IHC:1:20-1:200,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - NXPH2 (Neurexophilin 2 (NXPH2))
- 
                                            别名
- NXPH2
- 
                                            背景
- 
                        Background: May be signaling molecules that resemble neuropeptides and that act by binding to alpha-neurexins and possibly other receptors. Aliases: MGC125477 antibody, MGC125478 antibody, MGC125479 antibody, MGC125480 antibody, Neurexophilin 2 antibody, Neurexophilin-2 antibody, NPH2 antibody, Nxph2 antibody, NXPH2_HUMAN antibody 
- 
                                            UniProt
- O95156
 抗原
- 
                    
 
                                     
                                     
                                    